Eli Lilly CEO David Ricks on Q3 results: The underlying growth story is fantastic

Поделиться
HTML-код
  • Опубликовано: 28 янв 2025

Комментарии • 9

  • @sweetiemcgee
    @sweetiemcgee 3 месяца назад +3

    priced for perfection. im waiting.

  • @evanetter
    @evanetter 3 месяца назад +4

    The amount of fake commenters on all CNBC videos is both annoying and concerning.

  • @bhupesh0111
    @bhupesh0111 3 месяца назад +5

    $1850 by 2030!

  • @ocean694
    @ocean694 3 месяца назад +2

    The peak is over. It will go back to normal growth.

  • @fitbh703
    @fitbh703 3 месяца назад +2

    Still seems overvalued

  • @imperfectlyholistic
    @imperfectlyholistic Месяц назад

    If RFJ JR takes over the health department, I see Eli Lilly going up to over 1600.

  • @RC-iv4dx
    @RC-iv4dx 3 месяца назад +4

    drop your prices so insurance companies will cover this medicine Mr Ricks if your worried about compound medicines! then people wont use compounds!

  • @HellenVanPattersonPatton80
    @HellenVanPattersonPatton80 2 месяца назад

    Ricks is kind of a tool. Not up to the job. He's kind of talking in circles. Fire and replace your supply chain managers already.
    Bring Dr Lechleiter back.